APA (7th ed.) Citation

Brings, A., Lehmann, M., Foerster, K., Burhenne, J., Weiß, J., Haefeli, W. E., & Czock, D. (2019). Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers. British journal of clinical pharmacology, 85(7), . https://doi.org/10.1111/bcp.13934

Chicago Style (17th ed.) Citation

Brings, Antonia, Marie-Louise Lehmann, Kathrin Foerster, Jürgen Burhenne, Johanna Weiß, Walter E. Haefeli, and David Czock. "Perpetrator Effects of Ciclosporin (P-glycoprotein Inhibitor) and Its Combination with Fluconazole (CYP3A Inhibitor) on the Pharmacokinetics of Rivaroxaban in Healthy Volunteers." British Journal of Clinical Pharmacology 85, no. 7 (2019). https://doi.org/10.1111/bcp.13934.

MLA (9th ed.) Citation

Brings, Antonia, et al. "Perpetrator Effects of Ciclosporin (P-glycoprotein Inhibitor) and Its Combination with Fluconazole (CYP3A Inhibitor) on the Pharmacokinetics of Rivaroxaban in Healthy Volunteers." British Journal of Clinical Pharmacology, vol. 85, no. 7, 2019, https://doi.org/10.1111/bcp.13934.